Concepedia

Katja Schlichtig

KS

Statistics

Publications

4

Citations

143

H-Index

4

Active since

2021

Affiliations

Friedrich-Alexander-Universität Erlangen-Nürnberg(Current)

Universitätsklinikum Erlangen

Comprehensive Cancer Center Erlangen

Katja Schlichtig is an author at Friedrich-Alexander-Universität Erlangen-Nürnberg specializing in drug monitoring, oncology, and drug discovery.

Top concepts

Publications per year

2021–2023

4

Publications

4

The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents

Pauline Dürr, Katja Schlichtig, Carolin Kelz et al. · Journal of Clinical Oncology · 2021 · 96 citations · Full text

Medication Errors During Treatment with New Oral Anticancer Agents: Consequences for Clinical Practice Based on the AMBORA Study

Katja Schlichtig, Pauline Dürr, Frank Dörje et al. · Clinical Pharmacology & Therapeutics · 2021 · 25 citations · Full text

An Easily Expandable Multi-Drug LC-MS Assay for the Simultaneous Quantification of 57 Oral Antitumor Drugs in Human Plasma

Niklas Kehl, Katja Schlichtig, Pauline Dürr et al. · Cancers · 2021 · 12 citations · Full text

, , +21

Optimizing Medication Safety with Oral Antitumor Therapy: A Methodological Approach for the Real-World Implementation of the AMBORA Competence and Consultation Center

Lisa Cuba, Katja Schlichtig, Pauline Dürr et al. · Healthcare · 2023 · 10 citations · Full text

1–4 of 4